AlAhli Healthcare Trading Equity Fund

Ranked 2 out of 4 in - Pharmaceuticals & Health Care over 12 months
All calculations are in USD unless stated

Objective

The fund seeks long term capital growth. It seeks to achieve competittive returns during the medium to long term (3 years or more) through investing in Health care and health care related companies listed in the global markets.

We are currently building our database of fund managers for funds registered for sale in GCC countries. For any questions or to add fund manager information please contact info@citywiremiddleeast.com.
Filter fund managers & funds by availability across specific markets:

Performance

Pharmaceuticals & Health Care over : 31/10/2019 - 31/10/2020

Total Return

Quarterly Performance

to 30/09/2020 Annual Q1 Q2 Q3 Q4
2020 -9.2% 16.3% 4.5%
2019 21.6% 9.8% 1.1% -2.5% 12.4%
2018 -0.1% -1.8% 2.9% 9.6% -9.7%
2017 14.1% 9.7% 4.6% 2.9% -3.4%
2016 -12.3% -13.3% 4.8% 4.8% -7.9%
2015 4.4% 7.1% -1.5% -10.4% 10.5%
2014 16.3% 7.1% 4.7% 0.4% 3.3%
2013 34.9% 13.5% 3.0% 5.4% 9.6%
2012 16.5% 10.4% 2.1% 5.5% -2.1%
2011 1.3% 2.5% 5.9% -8.3% 1.7%
2010 1.1% 1.2% -10.7% 9.0% 2.6%
2009 17.0% -9.3% 9.7% 10.2% 6.7%
2008 -21.8% -9.0% -0.4% 0.2% -13.8%
2007 -1.9% 1.4% -0.5% 0.5% -3.3%
2006 7.8% 1.3% -1.9% 8.3% 0.2%
2005 14.7% -1.6% 4.8% 7.0% 4.1%
2004 6.2% 1.1% 1.6% -3.3% 6.9%
2003 21.8% -1.6% 13.0% 0.0% 9.5%
2002 -15.7% 1.9% -12.4% -10.4% 5.4%
2001 -6.5% -12.1% 8.8% -5.3% 3.2%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. Saudi Arabia

Fund Info

  • Launch date30/10/2000
  • Share Class size37Mn
  • Base currencyUSD

Purchase Info

  • Min. initial investment2,000
  • Min. regular additional investment1,000

Charges

  • Annual management1.85%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).